Visionary Holdings appoints Wenxuan Cai as CEO of GV Hong Kong

Visionary Holdings (GV) announced that its wholly owned subsidiary, Visionary Health Technology Group, has official appointed Wenxuan Cai as CEO of GV Hong Kong. In parallel, the GV Hong Kong has established a new wholly owned subsidiary in Nanjing, China, dedicated primarily to sales execution and market development. As CEO of GV Hong Kong, Ms. Cai will focus on: Building and leading regional sales and marketing teams; Executing go-to-market strategies for GV’s offerings in the fields of cellular rejuvenation and aesthetic treatment; Expanding institutional, channel, and strategic partnerships; Driving sustainable revenue growth and enhancing sales visibility. The newly established Nanjing entity will serve as frontline commercial platforms, handling regional sales operations and channel development. Combined with GV’s Asia-Pacific platform in Hong Kong, the Company has completed a fully integrated commercial structure spanning strategy, products, and sales execution. This development signals that GV’s commercialization efforts are now actively operational and scalable.